Searched over 200M research papers for "feso4 dose"
10 papers analyzed
These studies suggest that ferrous sulfate (FeSO4) is effective and well-tolerated for iron supplementation and anemia treatment, with specific dosing and administration methods varying based on the population and condition being treated.
20 papers analyzed
Ferrous sulfate (FeSO4) is a commonly used iron supplement for treating iron deficiency and anemia. Understanding the appropriate dosage and its effects is crucial for optimizing treatment outcomes and minimizing side effects. This article synthesizes findings from recent research on FeSO4 dosage, focusing on its safety, efficacy, and absorption characteristics.
A study involving non-anemic, healthy adults assessed the safety of different FeSO4 supplementation modalities, including daily doses of 60 mg and weekly doses of 420 mg. The results indicated that these dosages did not significantly affect iron status parameters, markers of inflammation, or susceptibility to infections and bacterial proliferation. Adverse events were minimal, suggesting that FeSO4 is well-tolerated in this population.
In a study of 1-year-old infants, a daily dose of FeSO4 drops (approximately 3 mg of iron per kilogram per day) was compared with a placebo over three months. The findings showed no significant difference in the frequency of gastrointestinal side effects between the iron-treated and placebo groups, indicating that moderate-dose FeSO4 therapy is safe for infants.
Research comparing alternate day dosing with consecutive daily dosing of 60 mg FeSO4 in iron-deficient women found that alternate day dosing led to higher fractional absorption of iron. This was attributed to differences in hepcidin production, a hormone that regulates iron absorption. The study suggests that alternate day dosing may be more effective for improving iron absorption.
A randomized controlled trial compared the efficacy of oral FeSO4 (325 mg thrice daily) with intravenous ferric carboxymaltose in treating postpartum anemia. While both treatments were effective, the intravenous option resulted in a faster and more reliable increase in hemoglobin levels. However, FeSO4 remains a viable oral treatment option for postpartum anemia.
A study involving male blood donors demonstrated a high correlation between the change in serum iron levels and iron absorption after administering a 100 mg dose of FeSO4. This suggests that monitoring serum iron increase can be a reliable method for assessing iron absorption from FeSO4 supplements.
In a trial comparing FeSO4 with NaFeEDTA, it was found that while FeSO4 was well absorbed, it also led to a significant increase in non-transferrin-bound iron (NTBI), which can be harmful. NaFeEDTA, on the other hand, was effective in treating iron deficiency with a lower risk of NTBI formation, indicating it may be a safer alternative for some patients.
Ferrous sulfate (FeSO4) is a widely used and generally well-tolerated iron supplement for various populations, including healthy adults, infants, and iron-deficient women. While daily and alternate day dosing strategies are both effective, alternate day dosing may enhance iron absorption. Monitoring serum iron levels can help assess the efficacy of FeSO4 supplementation. Comparisons with other iron compounds suggest that while FeSO4 is effective, alternatives like NaFeEDTA may offer benefits in terms of safety. Overall, FeSO4 remains a cornerstone in the management of iron deficiency and anemia.
Most relevant research papers on this topic